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Abstract
RNA interference (RNAi) provides an effective method to silence gene expression and investigate gene function. However, RNAi tools for the
chicken embryo have largely been adapted from vectors designed for mammalian cells. Here we present plasmid and retroviral RNAi vectors
specifically designed for optimal gene silencing in chicken cells. The vectors use a chicken U6 promoter to express RNAs modelled on
microRNA30, which are embedded within chicken microRNA operon sequences to ensure optimal Drosha and Dicer processing of transcripts.
The chicken U6 promoter works significantly better than promoters of mammalian origin and in combination with a microRNA operon expression
cassette (MOEC), achieves up to 90% silencing of target genes. By using a MOEC, we show that it is also possible to simultaneously silence two
genes with a single vector. The vectors express either RFP or GFP markers, allowing simple in vivo tracking of vector delivery. Using these
plasmids, we demonstrate effective silencing of Pax3, Pax6, Nkx2.1, Nkx2.2, Notch1 and Shh in discrete regions of the chicken embryonic
nervous system. The efficiency and ease of use of this RNAi system paves the way for large-scale genetic screens in the chicken embryo.
© 2006 Elsevier Inc. All rights reserved.
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Introduction
The chicken embryo is one of the main model systems for
analysing vertebrate development (Brown et al., 2003), but
simple efficient systems for reverse genetic analysis are under-
developed. RNA interference is now widely used as a tool for
the analysis of gene function, providing a quick and low cost
means for silencing gene expression. In Caenorhabditis elegans
and Drosophila melanogaster cells, long (>30 bp) double
stranded RNAs are routinely employed and a number of
genomic scale genetic screens using RNAi have now been
undertaken (reviewed in Friedman and Perrimon, 2004). In
mammalian cells, long double stranded RNAs are not generally
used for RNAi because they can trigger the interferon response
(Stark et al., 1998). As part of this response, double stranded
RNA activates PKR which in turn phosphorylates eIF2α
leading to global translational arrest (Manche et al., 1992) and
induces 2′,5′-oligoadenylate synthetase (OAS) which activates
ribonuclease L leading to non-specific mRNA degradation
(Minks et al., 1979). In contrast, short double stranded RNAs
(21–23nt) trigger specific gene silencing and are now widely
used (Elbashir et al., 2001). Although the interferon response
was originally discovered in the chicken and chick embryos
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(Isaacs and Lindenmann, 1957), it has been reported that long
double stranded RNAs lead to specific gene silencing in the
embryo (Pekarik et al., 2003). Perhaps even more surprising is
the observation that simply electroporating a chicken embryo
upregulates OAS expression yet this does not lead to the
characteristic non-specific mRNA degradation. Moreover,
despite inducing OAS, no developmental defects caused by
the electroporation procedure have been reported (Chesnutt and
Niswander, 2004). This may indicate that other components of
the interferon pathway such as ribonuclease L are not active in
the embryo.
Chemically synthesised short interfering RNAs (siRNAs)
have also been used to efficiently silence gene expression in the
chicken embryo (Hu et al., 2002). Whilst siRNAs and long
double stranded RNAs may be effective, vector-based RNAi
can provide stable long-term expression of siRNA and allows a
marker gene to be directly linked to the siRNA expression
cassette, enabling accurate in vivo tracking of silenced cells.
Moreover libraries of RNAi vectors are far more suitable for
distribution as a cheaply renewable resource than siRNAs or
double stranded RNA.
Early attempts at vector based RNA in mammalian cells used
short hairpin RNAs of varying length (Brummelkamp et al.,
2002; Paddison et al., 2002) but more recently hairpins based on
naturally occurring microRNAs (miRNAs) have been utilised
(Zeng et al., 2002). Endogenous miRNAs, typically ∼80
nucleotides in length are frequently expressed as much larger
precursor transcripts known as pri-miRNAs and can be linked
together in transcriptional operons (Lee et al., 2002; Hubbard et
al., 2005) which are initially processed by Drosha to produce
pre-miRNAs and then subsequently by Dicer to produce siRNA
(Kim, 2005). For optimal excision from primary transcripts,
Drosha requires unstructured flanking sequences surrounding
the miRNA hairpin (Zeng and Cullen, 2005). Recent studies
have shown that shRNAs are more efficient substrates than
siRNAs for silencing gene expression (Siolas et al., 2005).
Furthermore, synthetic miRNAs are better Dicer substrates than
shRNAs and lead to greater siRNA production and gene
silencing (Boden et al., 2004; Silva et al., 2005; Dickins et al.,
2005). The pre-miRNA processing and target mRNA cleavage
pathways are functionally coupled and RISC, which consists of
DICER, TRBP and Argonaute2 in humans, displays nearly 10-
fold better activity when programmed with a DICER substrate
rather than an equivalent siRNA, which explains the differing
efficiencies of siRNAs and shRNAs/miRNAs in gene silencing
(Gregory et al., 2005). On the basis of these observations,
comprehensive libraries of vectors for the human and mouse
genome have now been constructed which utilise synthetic
miRNA30-based hairpins to ensure optimal access to RNA
interference machinery and efficient gene silencing (Silva et al.,
2005).
A number of reports have described the use of the
heterologous mouse U6 or human H1 promoters (Katahira
and Nakamura, 2003; Bron et al., 2004; Chesnutt and
Niswander, 2004; Dai et al., 2005) to drive expression of
conventional short hairpin (sh)RNAs and silence gene expres-
sion in the chicken embryo by RNAi. However, the efficiency
of these mammalian promoters has not been compared with the
equivalent chicken promoters in vivo. Within the vertebrate U6
promoter, the proximal sequence element (PSE) has been shown
to influence species specificity (Simmen et al., 1992) and within
human U6 promoters, minor variations in the proximal
sequence elements profoundly influence their transcriptional
efficiency (Domitrovich and Kunkel, 2003). Examination of the
proximal sequence elements of chicken U6 promoters with
other vertebrates (Dai et al., 2005; Kudo and Sutou, 2005)
reveals differences in the PSE elements and, given the
sensitivity of these promoters to minor variations in the PSE,
we considered that mammalian U6 promoters might not be the
most suitable for RNA interference in the chicken.
Here we have generated an RNA interference system tailor-
made for chickens which utilises a potent chicken U6 promoter
driving expression of a modified chicken microRNA operon.
The efficiency of gene silencing with this system is comparable
with the best vectors available for mammalian cells and even
allows dual gene silencing from a single plasmid.
Materials and methods
Cloning chicken U6 promoters and vector construction
Isolation of the chicken chromosome 18U6 snRNA promoter was carried out
as follows: theXenopusU6 snRNA sequencewas used to search the chicken EST
database (Boardman et al., 2002). Surprisingly, several EST matches were found
with 100% sequence identity to nucleotides 11–107 of the Xenopus U6 snRNA,
which probably resulted from aberrant transcription of the RNA polymerase III
promoter by RNA polymerase II. Based on the sequence identity, two
oligonucleotides were synthesised, A + B (oligonucleotides used in cloning
are detailed in Supplementary Table S1) and used to PCR amplify a fragment of
the U6 snRNA gene using chicken DT40 genomic DNA. This snRNA gene
fragment was radiolabelled and used to screen a gridded chicken bacterial
artificial chromosome (BAC) library. This resulted in the isolation of 14 positive
BACS. DNA sequence was obtained from a single BAC using oligonucleotide B
and used to amplify the U6 snRNA promoter together with a 27 nucleotide U6
snRNA leader sequence using oligonucleotides C + D. Following publication of
the chicken genome sequence (Hillier et al., 2004), the promoter was found to
originate from chromosome 18. To create the backbone vector to accept the
chickenU6 promoter, a monomeric red fluorescent protein gene (Campbell et al.,
2002) was subcloned on a blunt-ended BamHI–HindIII fragment into a blunt-
endedEcoRI site in pCAGGS to generate pCAGGSRFP. The amplified promoter
was subcloned into pCAGGSRFP on a HindIII–BamHI fragment to generate
pCAGGSSWU6. To generate the flanking sequence IV from the miRNA operon,
two oligonucleotides E and F were annealed and subcloned into pCAGGSSWU6
cut withKpnI andNheI. The flank V + VI sequence from the miRNA operon and
RNA polymerase II terminator was generated by annealing oligonucleotides G
and H and subcloning the DNA downstream of flank IV sequences on a SacI–
BamHI fragment to generate pCAGGSSWU6FLANKIV + V.
To clone the chicken chromosome 28 U6 promoter, a chicken genomic
DNA library in bacteriophage lambda was used to PCR amplify U6 promoter
DNA using a T7 promoter primer and oligonucleotide I whose sequence was
based on conserved regions of the U6 snRNA in human, mouse and Xenopus
U6 promoters. A nested PCR reaction was then carried out with the product
of the first reaction using the T7 promoter primer and oligonucleotide J and
the PCR product was subcloned into pGEM-T Easy (Promega). The U6
promoter was then PCR amplified using oligonucleotides K and L and
subcloned into the HindIII and BamHI sites of pCAGGSRFP to generate
pCAGGSRFPVENUU6. pRFPRNAi was generated by subcloning a KpnI–
BamHI fragment from pCAGGSSWU6FLANKIV + V into pCAGGSRFP-
VENUU6. pRFPRNAiA (Fig. 1b) was generated by annealing oligonucleo-
tides M and N and subcloning the fragment into the NheI–SphI sites of
pRFPRNAi, which substitutes the SacI site in pRFPRNAi for an AflII site
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since there is an internal SacI site in the chromosome 28 U6 promoter. The
mouse U6 promoter was amplified from pSILENCER U6 1.0 (Ambion) using
oligonucleotides O and P and subcloned on a HindIII–BamHI fragment into
pCAGGSRFP to generate pCAGGSRFPMOUSEU6.
RCASARNAi was built by Quikchange mutagenesis of RCAS(A) with
oligonucleotides Q and R which introduced a NotI restriction site upstream of
the unique ClaI restriction site and generated RCAS (A) NotI. EGFP was then
PCR amplified using oligonucleotides S and T from pEGFP-NI (Clontech) and
subcloned on a NotI fragment into RCAS (A) NotI. The 5′ NotI site was then
destroyed using Quikchange mutagenesis with oligonucleotides U and V to
generate RCASARNAi. RCASBRNAi was generated by Quikchange muta-
genesis of RCAS(B) with oligonucleotides Q and R which introduced a NotI
restriction site upstream of the unique ClaI restriction site.
Synthetic miRNA30 Construction
The gene-specific oligonucleotides for miRNA30 like hairpin synthesis are
shown in Supplementary Table S2, together with the sequences which they
target. The 22 nucleotide target sequences were chosen using the design tool at
www.genscript.com/ssl-bin/app/rnai. The 5′ base of the sense strand was altered
in all cases so that it mismatched the guide strand base to mimic the structure
found in endogenous miRNA30. Hairpins for the first miRNA cloning site were
generated by PCR using 10 ng of each gene-specific oligonucleotide together
with 100 ng of two generic flanking oligonucleotides W + X in a 50 μl reaction
using Pfu polymerase (Promega). PCR conditions were 2 min at 94°C followed
by 40 cycles of 30 s at 94°C, 30 s at 55°C and 45 s at 72°C using an Eppendorf
personal cycler. PCR products were gel purified, digested with NheI and SacI
and subcloned into pCAGGSSWU6FLANKIV + V. The miRNAs for genes
were then transferred downstream of the chromosome 28 U6 promoter in
pRFPRNAi on a KpnI–BamHI fragment to generate pRFPRNAi-GENE
NAME. The miRNA active against luciferase was also transferred downstream
of the mouse U6 promoter in pCAGGSMOUSEU6 on a KpnI–BamHI fragment.
The chicken U6 promoter and miRNA expression cassette for luciferase were
subcloned from pRFPRNAi-LUC into RCASARNAi on a NotI–ClaI fragment.
The Pax6B MOEC was transferred to RCASBRNAi on a NotI–ClaI fragment.
The chicken chromosome 28 promoter contains an internal SacI site which
precluded direct cloning of miRNA hairpins. Therefore, we constructed a
derivative where the SacI site was replaced with an AflII site to generate
pRFPRNAiA (Fig. 1) and this vector was used for subsequent studies. To
generate the double miRNA vector, the luciferase hairpin was firstly subcloned
into pRFPRNAiA using gene-specific oligonucleotides for luciferase together
with two generic flanking oligonucleotides Wand Yon an NheI–AflII fragment.
Gene-specific oligonucleotides for LacZ, suitable for use in the second hairpin
cloning site, were used together with two generic flanking oligonucleotides Z
and AA and the miRNA amplified using the conditions described above. The
second miRNA was subcloned into the AflII and SphI sites of pRFPRNAiA,
downstream of the luciferase hairpin. A single miRNAvector for LacZ was also
generated using gene specific oligonucleotides and oligonucleotides W + Yand
subcloning the PCR product into the NheI–AflII sites of pRFPRNAiA.
Tissue culture and transfections
Chicken DF-1 cells were maintained in Dulbecco's modified Eagles medium
(DMEM) + 10% foetal calf serum with 10% CO2 at 39°C. HEK293T cells were
maintained in the same growth medium with 5% CO2 at 37°C. Cells were
transiently transfected using lipofectamine 2000 (Invitrogen) and enzyme assays
carried out as described previously (Williams et al., 2005). The H1 promoter-
based RNA interference vector for TAP has been described previously together
with GFP-TAP (Williams et al., 2005).
In ovo electroporation
White Leghorn fertilised eggs were purchased from Henry Stewart and Co.
LTD (U.K.). Eggs were incubated at 38°C for 45 h (until embryos were
approximately stages 10–12, according to Hamburger Hamilton (HH) staging)
and windowed to reveal the embryo. Approximately 0.2–1 μl of gene-specific or
control RNAi vector (1 μg/μl, resuspended in H2O, plus 0.1% Fast green dye)
was injected into the lumen of the posterior portion of the developing neural tube.
When two RNAi vectors for the same gene were mixed for electroporation, the
concentration of each vector was 0.5 μg/μl. Embryos were submerged in 1× PBS,
and 1 mm electrodes (genetrodes, Genetronics, Inc.) 4 mm apart were placed on
either side of the embryo. A current of 27 V was applied across the electrodes
(6 × 10–50 ms pulses), using a TSS20 Ovodyne electroporator (Intracel).
Embryoswere cooledwith 1 × PBS, windows coveredwith parafilm and Fujifilm
sealon film and the eggs placed at 38°C. Embryos were dissected out either 24 h
or 48 h after electroporation (approximately HH stages 19–22). For luciferase
assays on electroporated embryos, HH stage 11–12 embryos were coelectropo-
rated with various concentrations of luciferase RNAi vector together with 100 ng
luciferase plasmid pGL3 (Promega) and 200 ng pcDNA-LacZ (Invitrogen).
Embryos were cultured for a further 24 h and the electroporated region of each
Fig. 1. RNA interference vectors for chicken cells. (a) Organisation of the pri-miRNA operon encoding miR-106a, 18b, 20b, 19b-2, 92-2 and 363. (b) Schematic of
pRFPRNAiA, RCASARNAi and RCASBRNAi. ThemiRNA expression cassette can be transferred from pRFPRNAi to RCAS vectors usingNotI andClaI restriction enzymes.
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neural tube was harvested, lysed in 80 μl of Reporter Gene Assay Lysis buffer
(Roche) and luciferase activity was determined as above. The percentage
luciferase knockdown was determined by comparison to the luciferase activity
measured following electroporation with an RNAi vector targeting GFP. Results
were normalised to the β-galactosidase activity measured in the lysate and the
results presented the averages from 9 independent embryo electroporations
carried out on three separate occasions. For retroviral electroporations, 1 μg/μl
RCASBRNAi-Pax6B together with 0.1 μg/μl pCAGGS-RFP was coelectropo-
rated into HH stage 12–14 embryos.
Fixation and sectioning
Embryos were dissected from the eggs, rinsed briefly in 1× PBS and fixed in
4% paraformaldehyde on ice for up to 2 h depending on the stage. They were
then rinsed in 1× PBS and stored overnight in 30% sucrose (in 0.2 M phosphate
buffer). Embryos were viewed under a DM5000B fluorescent microscope
(Leica) to determine the RFP-positive segments, which were dissected out,
frozen in optimal cutting temperature (OCT) compound (VWR International),
sectioned to a thickness of 15–20 μm using a cryostat (Bright) and placed on
Superfrost Plus microscope slides (VWR).
Immunohistochemistry and imaging
Slides were rinsed in 1× PBS and incubated overnight at 4°C in appropriate
primary antibody solution (1:50 dilution of antibody obtained from Develop-
mental Studies Hybridoma Bank, University of Iowa; 1:10 dilution for the Gag
antibody in 1× PBS containing 0.1% Heat Inactivated Goat Serum and 0.01%
Triton X100). For staining with the anti-neuron-specific β-tubulin TUJ1
(Covance), a 1:1000 dilution was used. Slides were rinsed in 1× PBS and
incubated for 30 min in secondary antibody solution (1:200 dilution of FITC-
conjugated anti-mouse IgG (Jackson ImmunoResearch) in 1× PBS containing
0.1% Heat Inactivated Goat Serum/0.01% Triton X100). Secondary antibody
solution was supplemented with 1:2000 dilution of TOPRO-3 iodide (Molecular
Probes) for nuclear counterstaining. For BrdU labelling, 50 μl of a 0.01 M
solution of BrdU (Sigma) dissolved in PBS was injected through an opening in
the vitelline membrane and the amniotic sac. The egg was resealed and the
embryo was incubated for an additional hour before harvesting. Sections were
treated with 45 units/ml Dnase 1 (Sigma) in TBS (50 mM Tris pH 7.5, 150 mM
NaCl) with 10 mM MgCl2 and 10 Mm MnCl2 for 60 min at 37°C to reveal the
epitope. The anti-BrdU antibody was used at 1:250 dilution and the secondary
antibody was Alexa Fluor 488 goat anti-mouse IgG (Molecular Probes) (1:250
dilution). Slides were rinsed in 1× PBS and mounted in Vectashield mounting
media (Vector). Images were obtained using a Leica DM RE confocal
microscope and a Nikon Microphot-SA.
Wholemount in situ hybridisation
Embryos were harvested 24 h after electroporation and fixed in 4%
paraformaldehyde/PBS for 16 h at 4°C. Wholemount in situ hybridisation was
performed as described previously (Ohyama et al., 2005) using digoxigenin
(DIG)-labelled (Roche) RNA probes. DIG-labelled antisense riboprobes were
generated from linearised plasmids encoding chick Notch1 (cut with BamHI and
transcribed with T3 RNA polymerase (Promega)) and chick Hes1 (cut with
HindIII and transcribed with T3 RNA polymerase (Promega)). Stained embryos
were photographed under a MZ12 stereomicroscope (Leica) using a Spot digital
camera (Diagnostic Instruments).
Results and discussion
Construction of a microRNA operon expression cassette
(MOEC)
Since synthetic miRNAs achieve significantly better silenc-
ing of genes than conventional shRNAs (Boden et al., 2004), we
decided to employ them for silencing chicken genes. To achieve
efficient processing of synthetic miRNAs by both DROSHA,
which preferentially excises hairpins found within unstructured
regions of RNA (Zeng and Cullen, 2005) and DICER, which
uses miRNAs as one of its natural substrates, we adapted a
chicken miRNA operon, conserved in other vertebrates,
encoding miR-106a, 18b, 20b, 19b-2, 92-2 and 363 (Hubbard
et al., 2005). The unstructured flanking sequences IV, V and VI
(Fig. 1a) were used to generate an expression cassette, preceded
by a 27nt U6 snRNA leader sequence to ensure optimal
expression (Paddison et al., 2004), into which multiple miRNAs
could be inserted (Fig. 1b). Synthetic miRNAs based on human
microRNA30 which has been used previously to silence genes
in mammalian cells (Zeng et al., 2002) were generated for
insertion in the miRNA operon expression cassette (MOEC) by
a single step PCR. The synthetic miRNAs retained the base of
the stem and loop sequences from miRNA30 but the remaining
stem was replaced by a gene specific 22 nucleotide sequence.
Comparison of promoters for MOEC expression
To find the most appropriate promoter for driving MOEC
expression, we first tested the human H1 promoter for gene
silencing using existing vectors known to work well in human
cells. pSUPER-TAP expresses a 19 bp stem shRNA active
against the human mRNA export factor TAP, which efficiently
depletes endogenous TAP in human cells and blocks mRNA
export (Williams et al., 2005). When pSUPER-TAP was
cotransfected into human 293T cells together with a GFP-TAP
expression vector, it led to a clear reduction in the number of
GFP-TAP-positive cells, compared with the control transfection
using an RNAi vector active against luciferase (Fig. 2). In
contrast, when the same plasmids were used in chicken DF-1
cells, we were unable to detect a convincing and reproducible
knockdown of GFP-TAP expression. This indicates that the
human H1 promoter does not function efficiently in chicken
cells and led us to investigate alternative promoters which may
be more suitable.
Chicken RNA polymerase III promoters may function
more efficiently in chicken cells than mammalian promoters,
therefore we cloned two different U6 promoters, located on
chicken chromosomes 18 and 28. These promoters were
subcloned into a pCAGGS based vector backbone which
expresses monomeric red fluorescent protein as a marker for
transfected cells (Fig. 1b). A MOEC containing a single
hairpin based on miRNA30 active against firefly luciferase
was inserted downstream of the two chicken and a single
mouse U6 promoter and used to test the ability of all three
promoters to silence luciferase in chicken DF-1 cells (Fig.
3a). The chicken promoter which maps to chromosome 28
consistently gave significantly higher levels of silencing
compared with the chicken chromosome 18 or mouse U6
promoter, when used at lower doses, indicating that it drove
the highest level of miRNA30-Luc expression. These results
are consistent with a recent study which showed that the
chromosome 18 chicken U6 promoter was less active than
the chromosome 28 promoter (Kudo and Sutou, 2005). It is
striking that the maximum knockdown of luciferase gene
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expression obtained in that study using conventional
shRNAs driven from a chicken chromosome 28 U6
promoter was only 47% in chicken cells. In contrast, the
vectors we describe here routinely achieve 90% silencing of
luciferase expression. These differences may in part be
attributed to the use of different target sequences, but
probably also reflect the enhanced Drosha and Dicer
processing associated with synthetic miRNAs.
To determine whether the chicken chromosome 28 U6
promoter also worked most efficiently in the embryo, we
carried out neural tube electroporations with both chicken
and mouse U6 promoters driving expression of the same
Fig. 3. RNA interference in DF-1 cells and the chicken embryo. (a) Comparison of chicken and mouse U6 promoters for silencing luciferase in DF-1 cells. Cells were
transfected with the indicated amounts of RNAi vector together with 200 ng of pGL3 luciferase expression vector and 200 ng pcDNA-LacZ. An RNAi vector for GFP
was used as a control (500 ng) and showed no silencing of luciferase. (b) Comparison of chicken and mouse U6 promoters for silencing luciferase in the neural tube.
Embryos were electroporated with the indicated amounts of RNAi vector together with 100 ng pGL3 and 200 ng pcDNA-LacZ. (c) Silencing EGFP in DF-1 cells.
Cells were transfected with 200 ng pEGFP-N1 (Clontech) together with 600 ng RNAi vector. (d) Dual silencing of LacZ and luciferase. An RNAi vector active against
GFP (500 ng) was used as a control. Cells were transfected with 50 ng of lacZ expression vector, 200 ng luciferase expression vector and 500 ng of the indicated RNAi
plasmids. The percentage knockdown of enzyme activities are shown for single and dual gene RNAi vectors, using the GFP RNAi vector as a control. For enzyme
assays, the results represent the averages from nine independent transfections carried out on three separate occasions, the error bar showing the standard deviation.
Transfection efficiencies were normalised by cotransfecting a β-galactosidase reporter, with the exception of the dual gene knockdown, where transfection efficiencies
were monitored by counting RFP positive cells.
Fig. 2. The human H1 promoter does not work efficiently in chicken cells. 200 ng GFP-TAP vector (human) together with 600 ng of either pSUPER-luciferase vector
(control) or pSUPER-TAP vector was transfected into either human 293Tor chicken DF-1 cells. Cells were fixed 48 h post-transfection and nuclei counterstained with
DAPI.
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MOEC which silenced luciferase and then carried out
luciferase assays on embryo lysates (Fig. 3b). At low
doses of RNAi vector, the chicken chromosome 28 promoter
was most efficient, yielding more than twofold better
silencing than the mouse U6 promoter, whilst the chicken
chromosome 18 promoter drove intermediate levels of
silencing. At higher doses of RNAi vector, all three
promoters led to 90% silencing of luciferase activity. In
general, the levels of RNAi vector required for silencing
luciferase in the embryo were considerably lower than those
required for silencing in tissue culture, which may reflect the
differences in the efficiency of DNA delivery using
electroporation compared with lipofection. The chromosome
28 chicken U6 promoter appears to be the most potent in
both tissue culture and the neural tube and was used for
further experiments since in cases where suboptimal target
sequences are used, silencing is likely to be greatest with
maximal expression of the miRNA.
To confirm reliable expression of the RFP marker in the
presence of active RNAi, we designed a vector based on
pRFPRNAi to silence GFP and used this in DF-1 cells (Fig. 3c).
This vector led to efficient GFP silencing, yet maintained
equivalent RFP expression, indicating that the RNAi effect was
specific and RFP expression was not compromised in cells
exhibiting an RNAi response.
Dual gene silencing
There is a degree of redundancy in many vertebrate gene
families, complicating functional analysis. To address this
problem, we took advantage of the fact that within a miRNA
operon, multiple genes can be targeted by several miRNAs, all
expressed from a common precursor pri-miRNA. A vector
based on pRFPRNAiA was constructed, carrying a miRNA
against luciferase followed by a miRNA for β-galactosidase.
Using this vector, we showed effective simultaneous silencing
of both genes in DF1 cells; moreover, the level of silencing for
each gene was comparable to that produced by vectors only
encoding a single miRNA (Fig. 3d).
Silencing of endogenous genes in the chicken embryo
To demonstrate the utility of these vectors for silencing
endogenous genes in the chicken embryo, we examined their
ability to silence genes encoding transcription factors in the
developing spinal cord by electroporation of pRFPRNAi-
derived plasmids. The number of vectors constructed, target
sequences and relative efficiencies are summarised in Table 1.
For each gene, we constructed at least two RNAi vectors,
although we found that in some cases only a single vector
worked well and in some cases, vectors completely failed to
silence the target gene. Electroporated cells were clearly
identified by expression of RFP and in all cases the overlays
of the RFP and FITC channels (staining for the endogenous
protein) with the luciferase control RNAi vector showed
yellow cells (Fig. 4a, left panels) indicating no effect on the
expression of the endogenous genes. Pax3, Nkx2.2 and Pax6
are normally expressed in the dorsal, ventral and intermediate
domains of the spinal cord, respectively (Fig. 4a). When
RNAi vectors specific for the transcription factors were
introduced, Pax3 protein levels were significantly reduced at
48 h using the Pax3 A vector, whilst Nkx2.2 showed a clear
knockdown as early as 24 h post-electroporation using the
Nkx2.2 B vector (Fig. 4a, right panels). The longer time taken
to see knockdown with Pax3 compared with Nkx2.2 may
reflect differences in the half lives of the proteins. For Pax6
silencing, we initially mixed two RNAi vectors targeting
different sequences and observed efficient silencing as early
as 24 h post-electroporation. Further electroporations using
the individual Pax6 RNAi vectors revealed that the Pax6A
vector may work less efficiently than the Pax6B vector, since
a yellow cell was observed in overlays (Fig. 4b), yet mixing
the vectors prior to electroporation did not appear to
compromise the efficiency of silencing (Fig. 4a).
To establish the efficacy of the pRFPRNAi-derived plasmids
in other neural tube cells, we electroporated hypothalamus and
spinal cord floor plate cells with RNAi vectors for Nkx2.1 and
Sonic hedgehog (Shh), respectively. Nkx2.1 gene expression
was silenced in the hypothalamus at 48 h (Fig. 4d) and Shh
Table 1
Target sequences and efficiency of knockdown achieved in this study
Vector Target gene Target sequence Embryos
electroporated
Embryos showing
significant knockdown
pRFPRNAi Nkx2.1 A Nkx2.1 GTCTAGGACTTGCATGTAAATA 5 5
pRFPRNAi Nkx2.1 B Nkx2.1 ATGTGAACCTGTAGCTGTATAA 4 2
pRFPRNAi Nkx2.2 A Nkx2.2 GCTGTTCAGACGCTGCCTTTGA 5 0
pRFPRNAi Nkx2.2 B Nkx2.2 ACCACTTGGTACAGGCGCAGCA 8 8
pRFPRNAi Pax3 A Pax3 TCCAAGCAGTACAGTCCATAGA 7 7
pRFPRNAi Pax3 B Pax3 TGGACAAAGTGCCTTTCATTAT 5 0
pRFPRNAi Pax6 A Pax6 TTTGTACACTGAAGGCATTATA 15 15
pRFPRNAi Pax6 B Pax6 GGCACCACTTCCACAGGTCTCA 20 20
pRFPRNAi Notch1 A Notch 1 ACACCAATGTAGTCTTCAAGAA 13 12
pRFPRNAi Notch1 B Notch 1 GGAAGATTCTGTTGGACTGAAA 5 0
pRFPRNAi Notch1 C Notch 1 CCGGCACGCTGATGGACGACAA 12 12
pRFPRNAi Notch1 D Notch 1 ACGCCAACTTCAACGGCCTCAA 10 10
pRFPRNAi Notch1 E Notch 1 ACGCCAACTTCAACGGCCTCAA 7 5
pRFPRNAi Shh A Shh GCTGTGAAGTAATTGGATTCAA 5 0
pRFPRNAi Shh B Shh ACAAGAAACTCCGAGAGATTTA 5 5
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Fig. 4. Silencing of endogenous genes in the chicken embryo. (a) A schematic of the expression domains for the transcription factors is shown at the top. Knockdown
of Pax3 by pRFPRNAi Pax3 A (top panels). Knockdown of Nkx2.2 by pRFPRNAi Nkx2.2 B (central panels). Knockdown of Pax6 by a mixture of pRFPRNAi Pax6
A and pRFPRNAi Pax6 B. Electroporation introduces the RNAi vector into one side of the neural tube, marked by the RFP positive cells, the other half acting as an
internal control. Transcription factors are stained with FITC. (b) Knockdown of Pax6 mediated by electroporation of single vectors. Knockdown of Pax6 by
pRFPRNAi Pax6 A (left panels). Knockdown of Pax6 by pRFPRNAi Pax6 B. (c) Shh knockdown in the floorplate by pRFPRNAi Shh B. (d) Nkx2.1 knockdown in
the hypothalamus by pRFPRNAi Nkx2.1 A. All experiments (a–d) are controlled using the luciferase RNAi vector; in each case, the overlay image of RFP positive,
electroporated cells and the FITC channel, staining for the endogenous protein, shows yellow cells demonstrating that the control vector does not silence the
endogenous gene. Cell nuclei are stained using TO PRO-3.
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expression was silenced in the floor plate at 24 h post-
electroporation (Fig. 4c), demonstrating that RNAi functional
analysis can be applied to a number of different cell types in the
chick neural tube.
To test the potential of these vectors in the investigation of
genes involved in neuronal differentiation, we constructed
vectors to silence Notch1. Loss of Notch1 expression was
initially assessed using in situ hybridisation (Fig. 5a, lower
panels) which clearly demonstrated silencing of Notch1
mRNA. We also examined the expression of Hes1 a
downstream target of Notch1 signalling (Jarriault et al.,
1995) and found that it was downregulated following Notch1
silencing (Fig. 5b, lower panels). However, some residual
Hes1 expression was detected which may be due to Notch1
signalling from unelectroporated cells. Notch1 signalling has
been shown to result in premature neuronal differentiation in
many vertebrate species (reviewed in Lewis, 1998). A
reduction of Notch1 protein in the chick neural tube is
therefore predicted to result in differentiation of the electro-
porated cells. This was assessed by examining the RFP
distribution in neural tube sections. Electroporation of a
luciferase RNAi plasmid resulted in cells expressing RFP
throughout the ventricular and mantle zones of the spinal cord
at 48 h post-electroporation (Fig. 5c, top left panel). In
contrast, cells electroporated with constructs targeting three
different sequences in the Notch1 mRNA were predominantly
located in the mantle region of the neural tube (Fig. 5c), with
few remaining in the ventricular zone. Since these results
were seen with RNAi vectors targeting different regions of
Notch1 mRNA, it is unlikely that they were caused by off
target effects. BrdU labelling analyses indicated that the
electroporated cells, expressing RFP, were not in S-phase
(Fig. 5d, right panels), and antibody labelling indicated that
these cells expressed the early neuronal marker TUJ1,
indicating premature neuronal differentiation (Fig. 5d, left
panels).
Fig. 5. Notch1 knockdown in the neural tube. (a) Wholemount in situ hybridisation to detect expression of Notch1 mRNA following RNAi with a Notch1 vector.
Electroporated region of the neural tube is marked by RFP fluorescence (top panel). Electroporated cells show loss of Notch1 mRNA expression (middle panel and
arrow in lower panel). (b) Wholemount in situ hybridisation to detect expression of Hes1 mRNA following RNAi with a Notch1 vector. Hes1 mRNA is significantly
reduced in the RFP-positive region of the neural tube (compare top panel with arrow in lower panel). (c) RFP distribution was examined in non-stained sections using a
luciferase RNAi vector as a control. Electroporation with Notch1A, Notch1C and Notch1D RNAi vectors resulted in premature migration of RFP-positive cells
towards the mantle zone of the neural tube. (d) Sections were also examined for differentiation by staining for BrdU (green) to mark proliferating neuroprogenitor cells
in the ventricular zone (right panels) and TUJ-1 (green) (left panels), which stains differentiated neurons of the mantle region, using a GFP RNAi vector as control.
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RCAS-based vectors for RNAi
There are situations where stable long-term RNAi is
desirable or vector delivery by electroporation is not feasible
which led us to develop complementary retroviral vectors for
RNAi. A replication competent avian splice (RCAS) vector (A
envelope) was generated (RCASARNAi) which carries a GFP
marker and an RCAS (B envelope) vector (RCASBRNAi) was
also produced (Fig. 1b). To confirm that RCASARNAi worked,
we transferred the MOEC for luciferase into RCASARNAi to
generate RCASA-Luc. DF-1 cells were transfected (approxi-
mately 20% of cells) with RCASA-Luc and the cells cultured
for a week. At this point, most cells were GFP positive,
indicating that the virus containing the Luc MOEC still
replicated efficiently in tissue culture. When the RCASA-Luc
stably transduced cell population was transfected with a
luciferase expression vector, luciferase expression was silenced
by 90% (Fig. 6a). These data indicate that the MOEC still
functions efficiently in the context of RCASARNAi and
provides a means to rapidly generate a stable population of
cells with a gene knockdown.
To confirm that the retroviral RNAi vectors worked in the
embryo, we used RCASBRNAi, whose envelope infects the
neural tube most efficiently (Homburger and Fekete, 1996),
carrying hairpin B active against Pax6 (Fig. 6b). This vector led
to silencing of Pax6 in the neural tube (Fig. 6b) and also showed
evidence of viral spread (Fig. 6c), which indicates that the
retroviral RNAi vectors can replicate in the chicken embryo and
the activity of the MOEC is not compromised in the context of
an RCAS vector. A range of different tissues in the chick
embryo have previously been targeted using RCAS vectors
which raises the possibility of carrying out loss of function
RNAi studies in tissues which are not readily electroporated.
In conclusion, we have generated plasmid and retroviral
vectors which allow low cost, efficient single or dual gene
silencing in the chicken embryo using RNA interference. The
simplicity of construction and use of these vectors coupled with
their reliability should now make it possible to carry out large-
scale genetic screens in the chicken using RNAi vector libraries.
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